AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 290: H2459-H2465, 2006. First published January 20, 2006; doi:10.1152/ajpheart.00750.2005
0363-6135/06 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
290/6/H2459    most recent
00750.2005v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (8)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giordano, A.
Right arrow Articles by Romano, M. F.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giordano, A.
Right arrow Articles by Romano, M. F.

Rapamycin antagonizes NF-{kappa}B nuclear translocation activated by TNF-{alpha} in primary vascular smooth muscle cells and enhances apoptosis

Arturo Giordano,1 Raffaella Avellino,2 Paolo Ferraro,1 Simona Romano,2 Nicola Corcione,1 and Maria Fiammetta Romano2

1Invasive Cardiology Unit, Clinica Pineta Grande, Castelvolturno; and 2Department of Biochemistry and Medical Biotechnology, University of Naples "Federico II," Naples, Italy

Submitted 17 July 2005 ; accepted in final form 14 January 2006

Several lines of evidence support the view that rapamycin inhibits NF-{kappa}B. TNF-{alpha}, a potent inducer of NF-{kappa}B, is released after artery injury (e.g., balloon angioplasty) and plays an important role in inflammation and restenosis. We investigated the effect of rapamycin on NF-{kappa}B activation and apoptosis in vascular smooth muscle cells (VSMCs) stimulated with TNF-{alpha}. Using EMSA, we found that TNF-{alpha} caused NF-{kappa}B nuclear translocation in VSMCs after 1 h of incubation. Rapamycin inhibited I{kappa}B{alpha} degradation, thereby preventing nuclear translocation. Activation of NF-{kappa}B was accompanied by an increase of Bcl-xL and Bfl-1/A1 proteins, detected by Western blot assay, whereas rapamycin prevented the TNF-{alpha}-induced enhancement of these antiapoptotic proteins. The extent of apoptosis of VSMCs exposed to TNF-{alpha} was significantly enhanced by rapamycin. The effect of rapamycin appeared to be independent of the phosphatidylinositol 3-kinase/Akt-protein kinase B survival pathway, because the phosphatidylinositol 3-kinase inhibitor wortmannin neither prevented I{kappa}B{alpha} degradation nor increased apoptosis of cells incubated with TNF-{alpha}. Finally, we demonstrate that the large immunophilin FK-506 binding protein FKBP51 is essential for TNF-{alpha}-induced NF-{kappa}B activation in VSMCs. Our findings show that rapamycin inhibits NF-{kappa}B activation and acts in concert with TNF-{alpha} in induction of VSMC apoptosis.

inflammation; restenosis; vascular injury



Address for reprint requests and other correspondence: M. F. Romano, Dept. of Biochemistry and Medical Biotechnology, Univ. of Naples "Federico II," via S. Pansini 5, 80131 Naples, Italy (e-mail: romano{at}dbbm.unina.it)




This article has been cited by other articles:


Home page
J Am Coll Cardiol IntvHome page
B. L. van der Hoeven, S.-S. Liem, J. Dijkstra, S. C. Bergheanu, H. Putter, M. L. Antoni, D. E. Atsma, M. Bootsma, K. Zeppenfeld, J. W. Jukema, et al.
Stent Malapposition After Sirolimus-Eluting and Bare-Metal Stent Implantation in Patients with ST-Segment Elevation Myocardial Infarction: Acute and 9-Month Intravascular Ultrasound Results of the MISSION! Intervention Study
J. Am. Coll. Cardiol. Intv., April 1, 2008; 1(2): 192 - 201.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2006 by the American Physiological Society.